Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
1,391
Showing 50 of 1,391
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MNPR | Monopar Therapeutics | 11/12 | 3 | 100% | +491.4% | +520.9% | +811.7% | +128.9% |
| 2 | SEZL | Sezzle Inc. | 21/40 | 3 | 95% | +472.8% | +556.6% | +669.1% | -33.7% |
| 3 | TOI | Oncology Institute, Inc. | 21/32 | 10 | 90% | +333.7% | +182.6% | +1983.3% | -60.4% |
| 4 | LBSR | Liberty Star Uranium & Metals Corp. | 21 | 5 | 48% | +325.8% | -2.3% | +1071.5% | -48.4% |
| 5 | TERN | Terns Pharmaceuticals, Inc. | 24 | 7 | 67% | +274.3% | +35.9% | +1049.7% | -63.6% |
| 6 | TDUP | Thredup Inc. | 30/31 | 7 | 90% | +254.0% | +224.2% | +652.2% | -68.7% |
| 7 | YELLQ | Yellow Corp | 38 | 16 | 68% | +248.7% | +184.1% | +628.1% | -67.2% |
| 8 | RLMD | Relmada Therapeutics, Inc. | 33/35 | 6 | 64% | +212.7% | +7.0% | +748.2% | -91.0% |
| 9 | PRCH | Porch Group, Inc. | 38 | 5 | 68% | +191.2% | +276.2% | +452.6% | -69.5% |
| 10 | SLNO | Soleno Therapeutics Inc | 89 | 10 | 91% | +190.3% | +55.5% | +455.3% | -48.9% |
| 11 | NBY | Novabay Pharmaceuticals, Inc. | 144 | 4 | 81% | +188.9% | +245.9% | +365.5% | -8.2% |
| 12 | TKNO | Alpha Teknova, Inc. | 33/35 | 13 | 73% | +184.3% | +59.2% | +556.3% | -42.8% |
| 13 | GIA | Gigcapital5, Inc. | 14/15 | 7 | 100% | +166.9% | +77.4% | +345.5% | +77.4% |
| 14 | PROK | Prokidney Corp. | 15 | 3 | 80% | +166.7% | +77.2% | +382.1% | -31.3% |
| 15 | LFMD | Lifemd, Inc. | 21 | 8 | 86% | +161.0% | +174.5% | +274.8% | -30.3% |
| 16 | AEVA | Aeva Technologies, Inc. | 21 | 4 | 100% | +158.0% | +141.1% | +285.9% | +16.4% |
| 17 | HROW | Harrow, Inc. | 19/23 | 6 | 68% | +156.7% | +79.5% | +469.8% | -32.2% |
| 18 | PHAT | Phathom Pharmaceuticals, Inc. | 23 | 6 | 100% | +154.8% | +43.5% | +472.1% | +14.6% |
| 19 | SMMT | Summit Therapeutics Inc. | 25 | 5 | 84% | +144.7% | +34.0% | +485.8% | -12.2% |
| 20 | LUMN | Lumen Technologies, Inc. | 17/18 | 5 | 100% | +135.0% | +79.3% | +411.6% | +1.5% |
| 21 | BFLY | Butterfly Network, Inc. | 15/17 | 4 | 93% | +133.6% | +76.7% | +330.4% | -26.1% |
| 22 | TUSK | Mammoth Energy Services, Inc. | 36/39 | 5 | 89% | +133.4% | +150.6% | +190.4% | -6.8% |
| 23 | VFF | Village Farms International, Inc. | 17 | 5 | 71% | +131.5% | +212.9% | +270.9% | -47.9% |
| 24 | CDIO | Cardio Diagnostics Holdings, Inc. | 15 | 3 | 100% | +127.2% | +59.7% | +221.8% | +59.7% |
| 25 | ALMS | Alumis Inc. | 129/154 | 15 | 78% | +124.7% | +201.9% | +345.3% | -59.9% |
| 26 | MGNX | MacRogenics Inc | 12 | 5 | 83% | +121.0% | +91.3% | +290.9% | -3.6% |
| 27 | STIM | Neuronetics, Inc. | 51/63 | 4 | 76% | +114.7% | +79.3% | +546.2% | -50.0% |
| 28 | STTK | Shattuck Labs, Inc. | 20 | 9 | 45% | +112.3% | -13.5% | +325.6% | -71.2% |
| 29 | HOVR | New Horizon Aircraft Ltd. | 56 | 4 | 64% | +111.3% | +60.9% | +728.4% | -55.0% |
| 30 | UAMY | United States Antimony Corp | 15 | 5 | 53% | +110.9% | +57.9% | +428.9% | -26.1% |
| 31 | ARQT | Arcutis Biotherapeutics, Inc. | 21 | 8 | 90% | +107.6% | +80.2% | +274.1% | -73.9% |
| 32 | EAST | Eastside Distilling, Inc. | 225/230 | 5 | 97% | +107.5% | +116.3% | +234.9% | -91.0% |
| 33 | PAPL | Pineapple Financial Inc. | 90 | 4 | 67% | +104.0% | +105.0% | +597.8% | -52.5% |
| 34 | GTHP | Guided Therapeutics Inc | 18 | 4 | 78% | +102.9% | +105.4% | +249.4% | -49.1% |
| 35 | BYRN | Byrna Technologies Inc. | 16/18 | 8 | 94% | +101.8% | +27.0% | +325.5% | -1.3% |
| 36 | VERA | Vera Therapeutics, Inc. | 53/54 | 15 | 94% | +101.5% | +138.8% | +166.5% | -12.0% |
| 37 | ZVIA | Zevia Pbc | 10 | 7 | 80% | +100.7% | +129.4% | +251.5% | -56.1% |
| 38 | ACRS | Aclaris Therapeutics, Inc. | 28 | 6 | 79% | +98.4% | +101.1% | +249.1% | -83.4% |
| 39 | NG | Novagold Resources Inc | 10/12 | 11 | 90% | +97.6% | +108.5% | +132.0% | -14.6% |
| 40 | ASPI | Asp Isotopes Inc. | 25/26 | 7 | 100% | +97.5% | +60.6% | +359.2% | +11.0% |
| 41 | INSW | International Seaways, Inc. | 12/18 | 3 | 100% | +95.3% | +95.3% | +100.9% | +89.8% |
| 42 | PRAX | Praxis Precision Medicines, Inc. | 41 | 9 | 100% | +95.2% | +111.2% | +124.5% | +13.4% |
| 43 | TRDA | Entrada Therapeutics, Inc. | 174/175 | 7 | 63% | +93.6% | +138.3% | +224.1% | -38.4% |
| 44 | CVI | Cvr Energy Inc | 84/93 | 4 | 100% | +90.7% | +91.6% | +127.7% | +60.6% |
| 45 | APLD | Applied Digital Corp. | 34 | 4 | 59% | +90.6% | +87.8% | +283.6% | -58.6% |
| 46 | BLTH | American Battery Materials, Inc. | 33 | 10 | 64% | +88.5% | +62.5% | +303.6% | -67.8% |
| 47 | CLOV | Clover Health Investments, Corp. /De | 16 | 4 | 50% | +88.3% | +5.0% | +255.1% | -36.0% |
| 48 | TYRA | Tyra Biosciences, Inc. | 36 | 6 | 83% | +86.8% | +113.7% | +122.2% | -43.3% |
| 49 | HYLN | Hyliion Holdings Corp. | 15 | 10 | 87% | +86.7% | +126.5% | +172.2% | -54.0% |
| 50 | CMPX | Compass Therapeutics, Inc. | 41/43 | 7 | 88% | +86.1% | +109.8% | +135.4% | -40.4% |
Showing 1-50 of 1,391